DNA Sciences, GlaxoSmithKline Study Links to Adverse Events | GenomeWeb

NEW YORK, June 17 - DNA Sciences and GlaxoSmithKline will collaborate to study SNPs related to certain drug-related adverse cardiovascular events, DNA Sciences said today.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.